Skip to main content

MDGL

MADRIGAL PHARMACEUTICALS, INC.
Last price
$519.83
As of

Active signals for MDGL

No recent signals on MDGL in the last 180 days.

Top institutional holders of MDGL (13F)

FundMarket value% portfolioQoQ
RENAISSANCE TECHNOLOGIES LLC$55.4M0.07%,
D. E. Shaw & Co., Inc.$51.6M0.03%>1000%
RENAISSANCE TECHNOLOGIES LLC$48.8M0.08%-30.5%
RENAISSANCE TECHNOLOGIES LLC$37.6M0.06%-14.3%
CITADEL ADVISORS LLC$27.4M0.00%,
CITADEL ADVISORS LLC$25.1M0.00%-27.9%
Point72 Asset Management, L.P.$18.9M0.03%,
D. E. Shaw & Co., Inc.$15.8M0.01%-66.0%
Bridgewater Associates, LP$12.7M0.05%,
Bridgewater Associates, LP$11.2M0.04%-30.8%
Point72 Asset Management, L.P.$2.9M0.00%-87.9%
Point72 Asset Management, L.P.$2.4M0.00%-10.0%
Bridgewater Associates, LP$2.1M0.01%-79.6%
TWO SIGMA INVESTMENTS, LP$419K0.00%,
D. E. Shaw & Co., Inc.$275K0.00%,

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, MDGL

See more MDGL signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track MDGL in your watchlist and get notified the moment a new signal fires.

Track MDGL on Kresmion →